## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors present APR-Score, a machine learning method for identifying aggregation-prone regions in protein sequences, reporting state-of-the-art accuracy with MCC 0.77, precision 0.89, and F1-score 0.87, validated by cross-validation and an independent test set, with code available on GitHub.
- **Visible evidence base** Abstract text only; no methodological details, dataset descriptions, or performance comparisons are provided
- **Missing materials affecting confidence** Full manuscript, training and test dataset descriptions, feature definitions, model architecture, cross-validation protocol, independent test set composition, baseline comparisons, and code repository contents

## Reviewer
- **Overall assessment** The abstract describes a potentially useful computational tool for protein aggregation prediction, but the evidence presented is insufficient to evaluate the core claims of state-of-the-art performance and methodological novelty. The reported metrics are promising, yet without details on dataset composition, feature engineering, model selection, and comparison to existing methods, the claims cannot be independently assessed. The work addresses a relevant biological problem, but the current abstract does not establish the technical soundness or scientific impact required for a high-profile venue.
- **Who would be interested in the results, and why** Researchers studying protein misfolding and aggregation in neurodegenerative and systemic diseases would find this tool relevant for identifying potential aggregation hotspots in disease-associated proteins. Computational protein designers and engineers could use APR-Score to screen sequences for aggregation propensity during design workflows. Additionally, the broader bioinformatics community interested in sequence-based prediction tools would be a potential audience.
- **Major strengths** The problem addressed is of clear biological and clinical relevance. The reported performance metrics (MCC 0.77, precision 0.89, F1-score 0.87) are strong if reproducible. The availability of the tool on GitHub is a positive step toward community adoption and transparency.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3  
  - R1-M4
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3, R1-M4
- **Assessment against Nature-style criteria**  
  Originality: The abstract does not clearly differentiate APR-Score from existing aggregation prediction methods, so novelty is not established.  
  Scientific importance: The problem is important, but the abstract does not demonstrate a significant advance over current state of the art.  
  Interdisciplinary readership: The work could appeal to structural biologists, computational biologists, and clinical researchers, but the abstract lacks sufficient context to engage a broad audience.  
  Technical soundness: The reported metrics are not supported by sufficient methodological detail to assess validity.  
  Readability for nonspecialists: The abstract is generally clear but uses technical terms without adequate explanation for a general scientific audience.
- **Recommendation posture** Currently not established from the provided evidence. The abstract presents promising results, but the lack of methodological and comparative detail prevents a supportive recommendation. The authors should provide the full manuscript and additional evidence to substantiate the claims.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The method achieved state-of-the-art accuracy with MCC 0.77, precision 0.89, and F1-score 0.87.  
- **Evidence pointer** Abstract, performance metrics section; location not provided  
- **Concern** The abstract reports performance metrics without providing any details on the dataset size, composition, or the definition of aggregation-prone regions. It is unclear how many protein sequences were used, whether the dataset is balanced, and how the ground truth labels were established.  
- **Why it matters** Without dataset details, the reported metrics cannot be interpreted. A small or biased dataset could inflate performance, and the absence of label definitions makes the results non-reproducible.  
- **Resolution test** Provide a detailed description of the training and test datasets, including sequence counts, label sources, and class balance. Report performance metrics with confidence intervals or standard deviations.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The method leverages a combination of sequence-based features and compiled sequence and structural features to achieve state-of-the-art accuracy.  
- **Evidence pointer** Abstract, methods description; location not provided  
- **Concern** The abstract does not specify which features were used, how they were computed, or how structural information was incorporated. The phrase "compiled sequence and structural features" is vague and does not allow assessment of feature relevance or redundancy.  
- **Why it matters** Feature selection is central to machine learning performance. Without knowing the features, the method cannot be reproduced, and the claim of novelty cannot be evaluated against existing approaches.  
- **Resolution test** List all features used, describe their computation, and explain how structural features were derived. Provide an analysis of feature importance or ablation studies.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Comparative validity  
- **Claim pointer** APR-Score demonstrated state-of-the-art accuracy.  
- **Evidence pointer** Abstract, performance claims; location not provided  
- **Concern** The abstract claims state-of-the-art performance but does not compare APR-Score to any existing aggregation prediction methods. No baseline algorithms or benchmark datasets are mentioned.  
- **Why it matters** The term "state-of-the-art" is only meaningful in comparison to prior work. Without a direct comparison, the claim is unsupported and potentially misleading.  
- **Resolution test** Include a comparative analysis against at least two or three established aggregation prediction tools on the same benchmark datasets, with statistical significance testing.

- **Concern ID** R1-M4  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Validation rigor  
- **Claim pointer** The method was evaluated through rigorous cross-validation on the training dataset and further validated on an independent test dataset.  
- **Evidence pointer** Abstract, validation description; location not provided  
- **Concern** The abstract does not specify the cross-validation scheme (e.g., k-fold, leave-one-out), the number of folds, or the relationship between the training and independent test datasets. It is unclear whether the independent test set was truly independent or derived from the same source.  
- **Why it matters** Inadequate validation can lead to overfitting and inflated performance estimates. The lack of detail prevents assessment of the robustness and generalizability of the method.  
- **Resolution test** Describe the cross-validation protocol in detail, including the number of folds and how the independent test set was constructed. Ensure no sequence overlap between training and test sets.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Abstract, background section  
- **Evidence pointer** Abstract, first sentence; location not provided  
- **Issue** The abstract states that protein aggregation is associated with numerous diseases but does not provide specific examples or context for why this is important.  
- **Required correction** Add one or two examples of diseases or biological processes affected by aggregation to strengthen the motivation.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Reproducibility  
- **Affected element** Abstract, availability statement  
- **Evidence pointer** Abstract, last sentence; location not provided  
- **Issue** The GitHub link is provided, but the abstract does not state whether the code is open-source, what dependencies are required, or whether a web server is available.  
- **Required correction** Clarify the availability of the code, including license, dependencies, and whether a user-friendly web interface is provided.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Readability  
- **Affected element** Abstract, results description  
- **Evidence pointer** Abstract, performance metrics; location not provided  
- **Issue** The metrics MCC, precision, and F1-score are reported without defining them or explaining their relevance to the prediction task.  
- **Required correction** Briefly define these metrics or explain why they are appropriate for evaluating aggregation prediction performance.

## Risk / unsupported claims
- The claim of "state-of-the-art accuracy" is unsupported without comparative benchmarks.
- The reported performance metrics (MCC 0.77, precision 0.89, F1-score 0.87) are not verifiable without dataset and validation details.
- The claim that APR-Score "harnessed the information embedded in compiled sequence and structural features" is not assessable without feature descriptions.
- The assertion that the method "demonstrated robustness and reliability" is not supported by the evidence provided in the abstract.
- The potential applications to therapeutic development and protein engineering are speculative and not substantiated by any results in the abstract.